<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EBA4ABCD-0394-4234-8808-94480506F83D"><gtr:id>EBA4ABCD-0394-4234-8808-94480506F83D</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900950"><gtr:id>25B48F7C-ECF8-4636-BA7A-510A20EB11ED</gtr:id><gtr:title>MRC/UCL Centre for Medical Molecular Virology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900950</gtr:grantReference><gtr:abstractText>Viral infection remains a threat to health. We would like to understand the mechanisms by which viruses cause diseases such as AIDS, hepatitis chicken pox as well as damaging the unborn fetus. We will do this by studying viruses isolated from patients and by looking at how the patients respond to viral infection. We hope that this will allow us to develop better vaccines or therapies to combat viral disease.</gtr:abstractText><gtr:technicalSummary>The proposed new UCL MRC Centre for Medical Molecular Virology builds on past achievements to develop three new programmes of research. These are host immune responses and immunity/immunopathology , viral genome associations with disease, and cellular molecules critical for viral replication. The focus remains on clinically relevant, persistent viral infections. Key to each programme, will be the establishment within the Centre of new technologies, including massively parallel sequencing and high-throughput screening, and sophisticated bioinformatic tools. These will support a systems biology approach to virus-cell and virus-host interactions. Our second objective is to develop our unique ?Bench to Bedside? 4-year PhD Programme. Science graduates will each have a clinical and a basic science supervisor and will develop a translational research project. MRC Centre funding of PhD studentships would allow us to develop virology training within this Programme.</gtr:technicalSummary><gtr:fund><gtr:end>2015-10-23</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-01-24</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2778089</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>6B1EF812-4011-445A-9CD4-3B3C1702D431</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-1</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Novel broadly neutralizing Llama VHH (FASSATI)</gtr:description><gtr:id>887E774A-7FEA-4F14-A97B-F2138022F8C4</gtr:id><gtr:impact>One paper to be submitted shortly.</gtr:impact><gtr:outcomeId>RvkADcwunwK-1</gtr:outcomeId><gtr:partnerContribution>Characterised VHH, area of binding, performed deep sequencing to demonstrate that novel VHH arised after immunization.</gtr:partnerContribution><gtr:piContribution>Developed and performed high through put screening to identify novel broadly neutralizing LLama VHH, identified three new VHH.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Biosciences</gtr:department><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>1346DF7D-AB3F-4323-BDE8-D04862C9E6FC</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-3</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Prof. Olivier Schwartz, Pasteur Institute, Paris (FASSATI)</gtr:description><gtr:id>A5DD44F1-8D5E-4485-ABD2-A33AFDD7C954</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:outcomeId>f5fSw2V8ESh-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever)</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Metbolism and Endocrinology</gtr:department><gtr:description>Dr Richard Benarous, Mutabilis, France</gtr:description><gtr:id>B0540058-73AE-4FCF-B011-4D05F35D817B</gtr:id><gtr:impact>Identified four new compounds with antiretroviral activity: they belong to a new class of antiretrovirals .</gtr:impact><gtr:outcomeId>5457b6521ba981.38549373-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise and library of 10,000 small chemical compounds selected from a 150,000 compounds library.</gtr:partnerContribution><gtr:piContribution>Performed novel high through put screening to identify host factos necessary for HIV-1 replication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Super-resolution imaging: probe development (GROVE)</gtr:description><gtr:id>4342F721-D180-49AC-8E8D-14A2C98BF0FF</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>VS3hguu22DK-1</gtr:outcomeId><gtr:partnerContribution>Project conception, development and application</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Professor Olivier Schwartz, Pasteur Institute, Paris</gtr:description><gtr:id>BAAFF96D-98E3-418B-ACB0-7A99C172EC1F</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:outcomeId>5457ac4d11b695.94540793-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever).</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Charles Bangham, Imperial College</gtr:description><gtr:id>76447E21-FDAC-4C94-A924-E045CA867053</gtr:id><gtr:impact>One paper in preparation, one grant application submitted to MRC.</gtr:impact><gtr:outcomeId>5457b2501774e5.76621581-1</gtr:outcomeId><gtr:partnerContribution>High through put sequencing of HIV-1 integration sites.</gtr:partnerContribution><gtr:piContribution>Discovered new host factor involved in HIV-1 replication that affects integration site selection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>WESTON VISITING PROFESSORSHIP (BENNY CHAIN)</gtr:description><gtr:id>5CB5AED5-4D4D-4317-A671-DE164EF6BB7D</gtr:id><gtr:impact>Led to award of a bilateral Weizmann/UCL grant (Making Connections programme) $100,000 over two years.</gtr:impact><gtr:outcomeId>LELqddr5Fsj-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biodim Laboratory</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>52A476D5-C444-4630-B838-0050B2772D6C</gtr:id><gtr:impact>Eleven new hits identified to be followed up</gtr:impact><gtr:outcomeId>JqQZtLmmEDh-1</gtr:outcomeId><gtr:partnerContribution>Provided chemical library of 10,000 compounds to perform screening and cherry picked compounds.</gtr:partnerContribution><gtr:piContribution>Developed a novel cell-based, high through put screening assay. Discovered a new cell target important for HIV-1 infection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Mike Stratton and Dr Elisabeth Murchison, Wellcome Trust Sanger Institute</gtr:description><gtr:id>4FAD4348-EFB1-4725-8D49-3E8D0F4697A2</gtr:id><gtr:impact>A paper describing the CTVT genome published in Science, another publication on the tumour transcriptional changes is in preparation.</gtr:impact><gtr:outcomeId>5457b4217ac7b4.58853469-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on the genome of CTVT</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the canine Venereal Transmissible Tumour (CTVT).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Peter Cherepanov, CRUK</gtr:description><gtr:id>75CF3E6D-46DB-4CCE-8D3E-1074344606C2</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:outcomeId>5457ad8c644f58.76072307-1</gtr:outcomeId><gtr:partnerContribution>Structural biology of transportin 3.</gtr:partnerContribution><gtr:piContribution>provision of expression constructs recomninat protein expression and methods for immunoprecipitation. Expertise on nuclear transport receptors.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre (CSC)</gtr:department><gtr:description>MRC Clinical Sciences Centre (R JENNER)</gtr:description><gtr:id>04897F12-BDEE-4409-8360-25ABA5A3FB55</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>WB6wnwKYuZ5-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scripps Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dennis Burton Lab Visit (MCCOY)</gtr:description><gtr:id>655F153D-2856-4B48-AEF2-564D4F1434B7</gtr:id><gtr:impact>not known yet</gtr:impact><gtr:outcomeId>aBNE6YgB9XE-1</gtr:outcomeId><gtr:partnerContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:partnerContribution><gtr:piContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Whitehead Institute for Biomedical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Whitehead Inst Biomed Res (R JENNER)</gtr:description><gtr:id>18417E58-4C05-40DE-B368-BD87FA8434EE</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>DaFeNLW8PEt-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Understanding the coordination of hepatitis C virus entry and humoral immune evasion (GROVE)</gtr:description><gtr:id>CAA1B2E2-BE78-4133-A7B6-0FE7E88491D9</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>LkAuGKtuzmr-1</gtr:outcomeId><gtr:partnerContribution>Access to clinical samples</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Llama VHHantobody fragments to neutralise viruses (WEISS)</gtr:description><gtr:id>B2FDE0B3-5208-4CF7-AA19-5781F21A8155</gtr:id><gtr:impact>Research papers and 1 patent filed</gtr:impact><gtr:outcomeId>bRwMQNRPNYh-1</gtr:outcomeId><gtr:partnerContribution>VHH technology</gtr:partnerContribution><gtr:piContribution>virology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>KCL Paul Lavender (R JENNER)</gtr:description><gtr:id>61BE3E41-2C8A-4FD7-BF8D-1D5D42DA8F2B</gtr:id><gtr:impact>resulting in publication 21876034</gtr:impact><gtr:outcomeId>BVmSYpbPoAz-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Christopher Moody and Dr Russell Kitson, University of Nottingham</gtr:description><gtr:id>53DB8865-0E55-4E74-AF6E-A8B1C20E2E21</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:outcomeId>5457af169abe74.94468630-1</gtr:outcomeId><gtr:partnerContribution>Provided new chemical compounds inhibitors of Hsp90</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 latency.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Sanger Centre collaboration (DAN DEPLEDGE)</gtr:description><gtr:id>8056F2FD-0654-411D-8B89-76AF68B93E69</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>KPcCokDmArC-1</gtr:outcomeId><gtr:partnerContribution>Shared knowledge, materials and resources leading to publication output (in progress)</gtr:partnerContribution><gtr:piContribution>Shared knowledge, materials and resources leading to publication output (in progress)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>London Centre for Nanotechnology (A FASSATI)</gtr:description><gtr:id>988EEB33-909C-4037-99FA-82FB108507DB</gtr:id><gtr:impact>a shared IMPACT PhD studentship for Dino Osmanovic</gtr:impact><gtr:outcomeId>issKpsD5DQq-1</gtr:outcomeId><gtr:piContribution>Collaboration with the London Centre for Nanotechnology (Bart Hoogemboom and Ian Ford), which resulted in a shared IMPACT PhD studentship for Dino Osmanovic</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Adrian Hill and Helen McShane Oxford supported by UCL CBRC grant (COLLINS)</gtr:description><gtr:id>A8691141-5AB6-4C21-989D-720512FBAB3A</gtr:id><gtr:impact>in progress</gtr:impact><gtr:outcomeId>A82MeHbBbYV-1</gtr:outcomeId><gtr:partnerContribution>Novel adjuvant molecules, TB antigens and models</gtr:partnerContribution><gtr:piContribution>Lentiviral vectors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Dr. Ian Taylor, MRC NIMR, Mill Hill (FASSATI)</gtr:description><gtr:id>0973CBB1-ACAC-4E6E-9AE5-2C0E77BEB623</gtr:id><gtr:impact>one paper in preparation</gtr:impact><gtr:outcomeId>fJ4246Npm7o-1</gtr:outcomeId><gtr:partnerContribution>co-crystal structure of Coumermycin-A1 and HIV-1 capsid protein</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of the antibiotic Coumermycin-A1 in blocking HIV-1 replication</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>National Facility for GMP production of lentiviral and AAV vectors for gene therapy (MARY COLLINS)</gtr:description><gtr:id>4645FCF3-E39F-4648-98B8-CDFAD7891F2F</gtr:id><gtr:impact>in progress (publications)</gtr:impact><gtr:outcomeId>ZPaahSggF9F-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Genetic Engineering and Biotechnology</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>862534C8-2653-4144-99F6-3229932E03E9</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-2</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>Mechanism of viral transport across nuclear pores (FASSATI)</gtr:description><gtr:id>DD539538-4D91-420E-9D6F-E8E3FBCF30CA</gtr:id><gtr:impact>One modelling paper (Phys. Rev. E. 2012), one review (Soft Matter 2013), one paper to be submitted shortly.</gtr:impact><gtr:outcomeId>GypEAdBAEgA-1</gtr:outcomeId><gtr:partnerContribution>Atomic force microscopy and physical modelling of nuclear pores.</gtr:partnerContribution><gtr:piContribution>Expertise on nucleo-cytoplasmic trafficking of viruses and large molecules.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>4BFB3700-51AF-4636-913A-5471E178B570</gtr:id><gtr:impact>in the process of testing the compounds</gtr:impact><gtr:outcomeId>osYUkdksaMH-1</gtr:outcomeId><gtr:partnerContribution>Provided novel lead compounds that inhibit the target identified in our high through put screening</gtr:partnerContribution><gtr:piContribution>Developed a novel high through put screening, cell-based assay. Discovered a new cell target important for HIV</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wurzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Wuerzburg Collaboration (STAUSS)</gtr:description><gtr:id>22416289-1AA8-404F-80EC-1E7D62E645BF</gtr:id><gtr:impact>TBA</gtr:impact><gtr:outcomeId>cpYahGdnEHR-1</gtr:outcomeId><gtr:partnerContribution>TBA</gtr:partnerContribution><gtr:piContribution>TBA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Marcus Dorner, Imperial College</gtr:description><gtr:id>57FB87A2-7FFB-45A8-AD9A-4B8EC7DF21D2</gtr:id><gtr:impact>experiments ongoing</gtr:impact><gtr:outcomeId>5457b3383d17e7.56862711-1</gtr:outcomeId><gtr:partnerContribution>Humanized mouse models for HIV-1 infection to test the effect of selective Hsp90 inhbitors on HIV-1 latency.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the effect of Hsp90 on regulation of HIV-1 latency, provided specific Hsp90 inhibitor.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Medical Molecular Virology</gtr:department><gtr:description>Professor Benny Chain, UCL and MRC Centre</gtr:description><gtr:id>B5460778-8E93-4A70-8FC9-EAC8CD77B5CB</gtr:id><gtr:impact>One MSc Thesis (Tse Wang) and one paper published in the journal Traffic</gtr:impact><gtr:outcomeId>5457ab20a51f24.87271310-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on biophysical properties of transfected DNA and on innate Immunity.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on nuclear import of DNA.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>UCL Dept Medicine (R JENNER)</gtr:description><gtr:id>92383246-2646-499B-BE68-0A6D9AFB58C9</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>RFZvUc32XBP-1</gtr:outcomeId><gtr:partnerContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:partnerContribution><gtr:piContribution>shared knowledge, materials &amp;amp; equipment leading to increased publication output</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Veronique Birault, GSK, Stevenage.</gtr:description><gtr:id>93614087-AD7A-4609-9B9D-5D812084F19A</gtr:id><gtr:impact>In the process of performing SAR studies with GSK compounds</gtr:impact><gtr:outcomeId>5457b530bc2508.60866385-1</gtr:outcomeId><gtr:partnerContribution>Provided lead compounds that target the new host factor discovered by us.</gtr:partnerContribution><gtr:piContribution>Provided data on a new host factor to be used as an antiretroviral target.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Population dynamics of T cell responses analysed using high-throughput sequencing of TCR repertoire (CHAIN)</gtr:description><gtr:id>B23C56F8-4E80-4F4F-9F34-FA44A3831D1B</gtr:id><gtr:impact>Still in progress</gtr:impact><gtr:outcomeId>YHN3NvnfLJg-1</gtr:outcomeId><gtr:partnerContribution>Immunisations and seqeuncing</gtr:partnerContribution><gtr:piContribution>Developemnt of software for seqeunce analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Ari Fassati collaboration (R JENNER)</gtr:description><gtr:id>3AD4A0D0-562E-4411-A749-D50BEB99044A</gtr:id><gtr:impact>na</gtr:impact><gtr:outcomeId>Ybe8AiJktGQ-1</gtr:outcomeId><gtr:partnerContribution>resulting in publication 20937817</gtr:partnerContribution><gtr:piContribution>intellectual input into research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Raymond Welsh Lab Visit (PEPPA)</gtr:description><gtr:id>1193E499-0BB7-4CC9-8C3B-EE9F67A40BEA</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>MjPBRLnXn2u-1</gtr:outcomeId><gtr:partnerContribution>development of valuable collaboration, also link with a planned project on regulatory potential of NK cells in HBV with the MRC unit in the Gambia</gtr:partnerContribution><gtr:piContribution>address how T cell regulation by NK cells contribute to overall disease pathogenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>UCL Paul Kellam (R JENNER)</gtr:description><gtr:id>D8C767C4-1132-404B-8135-6ABA394D3ABD</gtr:id><gtr:impact>awarded a grant of &amp;pound;99,940, outcomes (published material etc) yet to be recorded.</gtr:impact><gtr:outcomeId>XN1UqnE3m8p-1</gtr:outcomeId><gtr:piContribution>Collaboration with Paul Kellam resulting in a project grant from the UCLH/UCL Comprehensive Biomedical Research Centre.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk in Bloomsbury Festival (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3A4F41A2-67ED-48FE-A81D-F65E6FEEC3D3</gtr:id><gtr:impact>Cosy Science, &amp;quot;viruses are our friends&amp;quot;, The Marquis of Cornwallis pub, 2013 for 50+ local residents

raised public awareness</gtr:impact><gtr:outcomeId>rjJ3xB6Jpyc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Immunity and Transplantation Opening Symposium (GROVE)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4953BFD1-3F99-4C4E-AC21-4B099C362656</gtr:id><gtr:impact>The symposium was filmed and I worked with a video editor to create a digital version of the presentation for You Tube</gtr:impact><gtr:outcomeId>jFrjQxtVRof</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (x2), 2011</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>5380AD51-1EA6-49FC-AF6B-2553C4AC4290</gtr:id><gtr:impact>R Milne &amp;amp; G Towers visited 2 primary schools (Gayhurst and Mayflower), various activities for 50+ pupils

received many thank you letters and further questions from pupils</gtr:impact><gtr:outcomeId>e5djDHcErA6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary schools visits 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>81647D1E-923C-4FE8-9A5E-EE81BA70C6C6</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>oQdCZa47d1T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>mothers2mothers charity talk (A FASSATI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>80F32A32-D788-4D80-9E22-3DFF5B6667F3</gtr:id><gtr:impact>presented talk titled 'The Current AIDS Epidemic' to 25+ members of the adult public

all proceeds to mothers2mothers charity</gtr:impact><gtr:outcomeId>iyCSiDQGcTz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary School visits 2013 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C1BE81CA-ACED-4223-A497-015D7ABB4642</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>kRKg9aLvttF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Observer Interview (M COLLINS)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>E59D296F-5455-45CF-BB7E-6D3DA3EAA7ED</gtr:id><gtr:impact>&amp;quot;My Bright Idea&amp;quot;- Interview for The Observer, 24/4/11

na</gtr:impact><gtr:outcomeId>kk4jfoZcqF2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Y6 children &quot;Investigating microbes&quot; at the Oratory RC Primary School, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C8B9A843-C8D4-4F75-B08E-17F02DA9D88A</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4d88a239c4.34174376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Thomas More Institute talk (A FASSATI)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>965B4726-38F8-450C-BBF1-F8F6A3DC2AA6</gtr:id><gtr:impact>presented talk titled 'Conscience and Values in the Response to Infectious Diseases' given to 50+ adult members of the public

na</gtr:impact><gtr:outcomeId>A1xVzZUpZyf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture &quot;Conscience and values in the response to infectious diseases&quot;, Thomas More Institute, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1364E0BE-690C-4AD8-A7BC-971132DAEE31</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4ef0d3d475.73242472</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://thomasmoreinstitute.org.uk/papers/conscience-and-values-in-the-response-toinfectious-diseases/</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC@UCL Centenary Science Fair (ALL MEMBERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>817EC304-3EE8-4FE4-8867-3667BCDAAA2A</gtr:id><gtr:impact>500+ members of the public (families, adults, school children) attended a science fair held @ UCL, Centre members contributed 3 hands-on workshop stalls, and presented separate talks. The public were given opportunities to perform tasks associated with the work of the Centre, and asked questions/contributed to discussions about what the Centre does and general science queries. Feedback included saying children had increased interest in developing their science education and awareness of virology principles.</gtr:impact><gtr:outcomeId>p3GGr2CsPNH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carolton Primary School Visit 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C12B64F0-C592-4EA8-BBB8-2A26D99A9D60</gtr:id><gtr:impact>40 local school children attended open day in the Centre labs; consisted of interactive introductory talk, followed by lab rotations where pupils preformed DNA extractions, microscope work, pipetting skills, artwork. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>LYRo1vX4bhv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Social Mobility Foundation Students (G TOWERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>47133036-5C98-43B4-9FAF-DBCF7BD6F220</gtr:id><gtr:impact>We took 2 students for a week each in August.

The idea is that students from poor backgrounds who wouldnt normally be exposed to opportunities for work experience can be helped out.</gtr:impact><gtr:outcomeId>qXEWhb1QBUn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience pupils (x4)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>CF2CBB39-1100-4046-809B-7E1941A3601E</gtr:id><gtr:impact>high school students attending 1 week work experience placements in various member's labs; shadowing staff and performing experiments

Provided further encouragement to take further study/career directions in virology or biomedical sciences</gtr:impact><gtr:outcomeId>rHmWfaTeb77</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HIV &amp; AIDS (WEISS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B00E68D5-02B9-48FE-9BDF-CB840E062A7B</gtr:id><gtr:impact>too soon to say</gtr:impact><gtr:outcomeId>Yynt4xSYLKL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Live comment on the origin of the AIDS epidemic on Arise News (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A0CB5F3F-F3FD-4331-B0E6-CA8A7AE9B64B</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4ceb7ae763.69277745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.arise.tv/arise-news-show/africa-wrap-03-10-8501</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit Primrose Hill (STAUSS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B18FB5A1-1879-42FB-890F-1AC3C433C23C</gtr:id><gtr:impact>Parents attended a presentation of our research and all children attended an assembly

money raised for cancer research</gtr:impact><gtr:outcomeId>YBeV66JFrWi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Arts talk (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>579AC7E3-139C-416A-8EC5-237DF7E6294A</gtr:id><gtr:impact>presented talk titled 'Are Women Changing Science?'

na</gtr:impact><gtr:outcomeId>AtFwP8JVbAS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contribution to the Financial Times &quot;New synthetic life needs context and regulation&quot;(A. Fassati)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6F34CE4A-6691-4C87-B829-E8606D50BFC1</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a503dc26947.02633876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.ft.com/cms/s/0/3da6db20-6796-11df-a932-00144feab49a.html#axzz2hsOEkNfY</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture on the AIDS epidemic for the charity &quot;Mothers to Mothers&quot; London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CD422196-1245-450F-8036-9FE7FD770673</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4faae7f4d3.96174765</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.m2m.org</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture: City of London Boyrs School (B CHAIN)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>EF87CE2C-8A15-4D83-9941-AC8871C69C1A</gtr:id><gtr:impact>50+ pupils attended a lecture titled 'vaccinations'

na</gtr:impact><gtr:outcomeId>MuijEhdnd2i</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit, London (3 visits)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>89D94BEC-D6F1-4420-A2C5-E32316FA2C79</gtr:id><gtr:impact>50+ 6th form Biology students attended a talk given by Prof Mary Collins on both Virology and science careers.

Provided further insights to virology and encouraged studetns further in choosing scientific careers</gtr:impact><gtr:outcomeId>dw2NUHn8k6r</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture How does science contribute to our understanding of life? Institute of St. John, London.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0BCD2CB4-187E-4168-B712-95F69BB90EFC</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4e0c54f451.42980610</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lunchtime Lecture UCL (COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>37E48706-97BC-4AD4-9123-A4A47FF4F53A</gtr:id><gtr:impact>800 You tube hits</gtr:impact><gtr:outcomeId>Sp3KFk8iPsm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (STAUSS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FDA68F54-E685-4EF1-9E51-D673BE2F481A</gtr:id><gtr:impact>Approximately 200 lay people attended lecture on T Cell therapy

Lecture was recorded and is available on You-tube</gtr:impact><gtr:outcomeId>WAaSXnz3BP6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>237518</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (R JENNER)</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2F818F2D-14EA-420E-9CD9-AEB90CFD51A6</gtr:id><gtr:outcomeId>DsmkPR5ztg20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7 Innovative Medicines FP7-Health 2012-Innovation-1</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>HIVINNOV</gtr:fundingRef><gtr:id>5306FFAF-A05B-41A5-ADC2-D2FCBA1D2EC8</gtr:id><gtr:outcomeId>545a44887b4bc2.90936369</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept award (TOWERS)</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CBB8E251-FFE1-4E9A-A9B4-43C5790788CD</gtr:id><gtr:outcomeId>JWYCDRCvhkm</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13258</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Royal Society (GROVE)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>E8F40105-A522-4395-AB16-B3FCEF2B3FF8</gtr:id><gtr:outcomeId>XdAZUTHTmZU</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre Manchester</gtr:department><gtr:description>Pilot project grant award Africa Centre</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>ISSF/FHCE/0103</gtr:fundingRef><gtr:id>8CF12963-9236-4CDD-A6AF-5D4D44B07D17</gtr:id><gtr:outcomeId>545a464ce25412.60665491</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>327676</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant (STAUSS)</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0700149</gtr:fundingRef><gtr:id>EA18EB22-A0E9-4999-8C55-1C17B19F6ACF</gtr:id><gtr:outcomeId>QBifpTuabza</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>139082</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Phase I/II safety &amp;amp; toxicity trial (STAUSS)</gtr:description><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>1B8F73E5-440A-423B-A716-1C6B23962948</gtr:id><gtr:outcomeId>EL7rYLSGLWA</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>HIVINNOV EU FP7 (FASSATI)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>HIVINNOV, 305137</gtr:fundingRef><gtr:id>2E2EE786-78B8-4D7D-A1E4-B071DAEC7F06</gtr:id><gtr:outcomeId>DGrWSYDaXk6</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PROJECT GRANT (BENNY CHAIN)/GATES FOUNDATION GRAND CHALLENGE GRANT</gtr:description><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>9509F006-7B9D-45CD-8994-47B6ACA9CCBB</gtr:id><gtr:outcomeId>c3REKu9Px8h0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1499094</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starting Grant (JENNER)</gtr:description><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>E912F9FA-9194-4904-878F-58D0711D9A2B</gtr:id><gtr:outcomeId>DjKAh6wLjCr</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2499643</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Advanced Grant (TOWERS)</gtr:description><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>BFEFAEB2-8394-4383-A3F0-C8C1B48C5574</gtr:id><gtr:outcomeId>eYr3caZzWf1</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award 2013 (M COLLINS)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900950-E01/1</gtr:fundingRef><gtr:id>75F07365-BF4B-4C3E-97B2-228D8C5D4458</gtr:id><gtr:outcomeId>N4o4J7tZ3Na</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>Hungary, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biological Research Centre (BRC)</gtr:department><gtr:description>UCLH BRC Funding for Wolfson Gene Therapy Unit, 2013-2016 (M. Collins)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Hungarian Academy of Sciences (MTA)</gtr:fundingOrg><gtr:id>1ADD5CDA-F90E-4BF0-98FF-4EAE689F6293</gtr:id><gtr:outcomeId>546229937c0661.25620922</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Infection Immunity and Inflammation Theme (M COLLINS)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>408F528F-1F00-4029-AB49-08652F081071</gtr:id><gtr:outcomeId>sa7aWyqDLo3</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LupusUK Consumables Fund (R JENNER)/LupusUK</gtr:description><gtr:fundingOrg>LUPUS UK</gtr:fundingOrg><gtr:id>A51211A8-066B-4198-A437-2292B5E4F4F6</gtr:id><gtr:outcomeId>iPVjFAnbfru0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>540000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Unilever PLC (CHAIN)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Unilever</gtr:fundingOrg><gtr:id>66937DF6-1B7B-4EE0-9B34-804E7A2E8827</gtr:id><gtr:outcomeId>DTkaZewHixj</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>230607</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship (ii) (STUASS)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6ECCAA68-0AD8-4944-8F49-251C9CEE0685</gtr:id><gtr:outcomeId>GDEh2HYVB95</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>352900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L021404/1</gtr:fundingRef><gtr:id>7800CFC2-1664-4554-8D1A-A9492FBBC5A7</gtr:id><gtr:outcomeId>545a45a99349c8.28230913</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>CBRC grant award CBRC grant Measuring T cell repertoire perturbation in HIV infection (B CHAIN)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>8A0259E3-9A69-490E-9545-77F976C47E8B</gtr:id><gtr:outcomeId>dD2HG7NtDcd0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>641000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU Integrated Project Grant (STAUSS)</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F41FD13E-E38C-4F56-A871-558C090138FE</gtr:id><gtr:outcomeId>LJRVKzmiP1o</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140888</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>Biomedical Research Centre research grant (M COLLINS)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>51C64430-05D9-40BA-8F04-D7B08D1161CE</gtr:id><gtr:outcomeId>hthLNCAWtoi0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>345256</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU FP7 (TAKEUCHI)</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>603049</gtr:fundingRef><gtr:id>FD655921-D952-4CB9-8546-603A5B1FA4D0</gtr:id><gtr:outcomeId>QKhHQ3wpm4S</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1636000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU Marie-Curie Excellence Award (STAUSS)</gtr:description><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>F101EBCA-1AE2-4628-AC2D-5542B60EBA57</gtr:id><gtr:outcomeId>GshUigygTM8</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU FP7 CHAARM (WEISS)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>CHAARM</gtr:fundingRef><gtr:id>723F8A13-87C9-44BD-BD3C-55121E1979F0</gtr:id><gtr:outcomeId>R4LP6b2HNrq</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>256000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS (STAUSS)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5AD3B073-AB06-46C7-82CC-04DA0B71D6A3</gtr:id><gtr:outcomeId>Ww7Xuvy732G</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>141000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL/UCLH BRC Project Grant (COLLINS)</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>1798621C-9A53-463E-894F-19D4872B6917</gtr:id><gtr:outcomeId>BM49BdJCovB</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Peter Samuel Royal Free Fund (GROVE)</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Peter Samuel Trustees</gtr:fundingOrg><gtr:id>9E6D6AE6-677D-498D-BC5A-33CB5B1F5912</gtr:id><gtr:outcomeId>a4JAjkMEJbi</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>253094</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship (STAUSS)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E985D87D-D256-486B-9A0D-7BA247A6F8BA</gtr:id><gtr:outcomeId>Edozokcp7CM</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>112375</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Research Grant (TOWERS)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>2D08CF1F-7F80-4322-AF06-CA00579215FF</gtr:id><gtr:outcomeId>rjpTcb1dnvM</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>225820</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Research Training Fellowship (STAUSS)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A4066BEB-9325-4E37-8CA9-4FC78987B4A7</gtr:id><gtr:outcomeId>YTNv8RLkcRs</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 Innovative Medicines FP7-HEALTH-2012-INNOVATION-1 (FASSATI)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0F717434-6A9F-4B55-AA8D-65BFE68B29C1</gtr:id><gtr:outcomeId>tWhbBTfwgYQ</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK research grant (M COLLINS)</gtr:description><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>88D9244B-F7C7-4757-BFC4-F451EAFA6E07</gtr:id><gtr:outcomeId>fthfeLuov4u0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Rosetrees: relationship between vitamin D deficiency and the immune response (B CHAIN)</gtr:description><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>23757581-2AA8-4B1C-8154-0E0B37C344E9</gtr:id><gtr:outcomeId>e3BqCjWnU2r0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>NIHR UCL/UCLH Biomedical Research Centre grant (TOWERS)</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>722F3B45-C59C-42DC-A6EA-F239CFF1F1DF</gtr:id><gtr:outcomeId>am68aWeiuGB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship (MARY COLLINS)/University College London</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>7AF2D2E7-F7EA-4B34-9692-1CB6E84213F0</gtr:id><gtr:outcomeId>Lpi8TbKj6Vw0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>54996</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCL Business Proof of Concept Award (TOWERS)</gtr:description><gtr:fundingOrg>UCL Business</gtr:fundingOrg><gtr:id>56CA60EC-511F-43E1-A413-D8BD3FD21090</gtr:id><gtr:outcomeId>PweSmLDkaEq</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Experimental Medicine Grant (STAUSS)</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6586A0F1-3390-4F10-8490-FB2740F3626B</gtr:id><gtr:outcomeId>eJ5o4KqT2gQ</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>352900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L021404</gtr:fundingRef><gtr:id>6D4C454B-62EA-4F0F-9176-3E5464381AC3</gtr:id><gtr:outcomeId>545b953cb51443.31377239</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>182308</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Biomedical Research Fellowship Enhancement (TOWERS)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A82AE167-6D73-4B4F-A0B0-79945097C23F</gtr:id><gtr:outcomeId>srqFWnfERia</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>320000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DoH Phase I/II safety &amp;amp; toxicity trial (STAUSS)</gtr:description><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:id>970FA6B3-9978-4E39-963D-6818DC06B8B1</gtr:id><gtr:outcomeId>bkHksM2CUJQ</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1895702</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Programme Grant (STAUSS)</gtr:description><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>450A5D6E-CE0D-44CE-9E9A-973C68795102</gtr:id><gtr:outcomeId>VuspAoKw34H</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50711</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long-Term Fellowship (R JENNER)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>380DD3B0-DAD0-424A-A636-0ECB297BC9FB</gtr:id><gtr:outcomeId>HkXfaZRuzrM0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship - Khaled Sanber (M COLLINS)</gtr:description><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>34AC54B3-E8D0-443D-BDAF-37A334686E44</gtr:id><gtr:outcomeId>KMKhL2nG8Hw0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 HEALTH 2012 INNOVATION-1 (STAUSS)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C2547DCD-7289-42BC-AD7F-43AD849B0C49</gtr:id><gtr:outcomeId>Mb3Ap4HxJFk</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167920</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 ITN (STAUSS)</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F455E081-9171-4F89-9EF0-91FC360A5A6D</gtr:id><gtr:outcomeId>gv6M3BckDgN</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The LMP2-TCR may be used for TCR gene therapy of lymphoma and nasopharyngeal carcinoma. A patent has been filed for the theurapeutic exploitation of the LMPC-TCR</gtr:description><gtr:grantRef>G0900950</gtr:grantRef><gtr:id>864597DB-3FE4-4ADE-85D9-893688920DB7</gtr:id><gtr:impact>The LMP2-TCR may be used for TCR gene therapy of lymphoma and nasopharyngeal carcinoma. A patent has been filed for the theurapeutic exploitation of the LMPC-TCR</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>n9GvCbuoeca</gtr:outcomeId><gtr:patentId>US2011274675</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>LMP2-TCR (STAUSS)</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Stable cell line to continuously produce HIV vectors</gtr:description><gtr:grantRef>G0900950</gtr:grantRef><gtr:id>78DDAE59-E34C-4B40-A62F-5DC8E7B48F7C</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>cuizBW42539</gtr:outcomeId><gtr:patentId>WO2013121194</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Packaging cell line (M COLLINS)</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Potential use as vaginal microbicide and as tool for vaccine developent</gtr:description><gtr:grantRef>G0900950</gtr:grantRef><gtr:id>D99EE605-55AA-425E-8DEA-4722EB9E6D5D</gtr:id><gtr:impact>not yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>Rv1M7XX5XNR</gtr:outcomeId><gtr:patentId>INSUFFICIENT INFORMATION</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>HIV broadly neutralisng llama VHH (WEISS)</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>stable packaging cells for lentiviral vectors</gtr:description><gtr:grantRef>G0900950</gtr:grantRef><gtr:id>43B2876C-B507-4CE8-BBFD-A479FC76DB22</gtr:id><gtr:impact>stable packaging cells for lentiviral vectors</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>DxJPxnJxRUi</gtr:outcomeId><gtr:patentId>Insufficient Information</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>WinPAc cells (COLLINS)</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>NA</gtr:description><gtr:grantRef>G0900950</gtr:grantRef><gtr:id>58CBA36C-5C3C-4A3E-A04D-90AAD4F4E84F</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>cM5nXyiHoUX</gtr:outcomeId><gtr:patentId>GB1015305.4</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>patent application # 1015305.4 (R JENNER)</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>CMV Disease in transplant patients</gtr:description><gtr:grantRef>G0900950</gtr:grantRef><gtr:id>EDDF354B-BCC6-458E-B053-C916FB1FFAF9</gtr:id><gtr:impact>CMV Disease in transplant patients</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>BVqcvuUpg2v</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>CMV-TCR (STAUSS)</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member DH CTBVEAG (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>668F848D-A6F2-4FA2-97B3-8AE488793191</gtr:id><gtr:outcomeId>kho4eJVd9JT</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership to CSS2 committee of ANRS, France (FASSATI)</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>572A3A5E-309B-4850-9E66-D42A96976A85</gtr:id><gtr:outcomeId>rhc96AVvMjT</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FSA-MRC joint workshop (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>31B6E62B-59C4-434F-A429-94115820DFB1</gtr:id><gtr:impact>Participant in owrkshop which promotes opportunities for synergy between basic immunology and food allergy research</gtr:impact><gtr:outcomeId>NSzi8zyNjxg</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of DH Gene and Stem Cell therapy advisory committee (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>E620FF6D-BDFC-4EC2-AF8B-EB473AE06FA9</gtr:id><gtr:impact>Provides advice on policy and safety at national level</gtr:impact><gtr:outcomeId>FXTZECtDEya</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB CIRI, Lyon (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>FF82D4FF-185D-446A-A624-6AFA6D8CAA80</gtr:id><gtr:impact>improved research practices at CIRI</gtr:impact><gtr:outcomeId>RSG9ChjkZyV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>INSERM lentiviral vector course (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>DA86387F-F571-4902-9465-0BA86804D99A</gtr:id><gtr:impact>Provided advancement of training in this area to postgraduate+ level audiences</gtr:impact><gtr:outcomeId>CUs1a4i9Gir</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>'Bench to Bedside' PhD programme (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>D6C9F44B-C25A-4D1F-96DF-18B1FDD8F918</gtr:id><gtr:impact>Newly established studentship scheme providing translational context for basic sceince PhDs in area of Infection &amp;amp; Immunity</gtr:impact><gtr:outcomeId>TP4sNBEKb2S</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member sub-panel 1, REF (M COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C07788FB-F4F7-48A0-A5C6-5ACF51033F20</gtr:id><gtr:impact>contribution to determining research standards of national institutes</gtr:impact><gtr:outcomeId>A7ozvVLmxaa</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC (COLLINS)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3EC5661E-330E-431A-B74F-06C30563527C</gtr:id><gtr:impact>Uk trials for gene therapy approved</gtr:impact><gtr:outcomeId>Tj4mp1gftUJ</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EMBO course (MARY COLLINS)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>69F23FDB-52BB-4ADD-A803-AC5A7A50546C</gtr:id><gtr:impact>Provided advancement of training in this area to postgraduate+ level audiences</gtr:impact><gtr:outcomeId>ikc1gTT8k3Z</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Microbial safety and immune response in xenotransplantation</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>FA53304C-4C75-4860-9286-50E6A56AACF6</gtr:id><gtr:outcomeId>J2P8KGg9AF7</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SAB Heinrich Pette Institute (M COLLINS)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>7D7F7BE2-246A-45FE-A018-62E69A6602E1</gtr:id><gtr:impact>improved research practices at the Institute</gtr:impact><gtr:outcomeId>E3LkT11U1j7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Unilver sponsored workshop (BENNY CHAIN)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>D39CEFBE-74FD-4971-82AB-19E812FF61CA</gtr:id><gtr:impact>Invited planer speaker for 'T-lymphocytes: Orcehstrators of skin sensitisation'.</gtr:impact><gtr:outcomeId>U4edxhzvXgk</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>HIV potent and broad neutralising</gtr:description><gtr:id>2F8574B9-D08B-42A3-A589-5F0034976DD7</gtr:id><gtr:impact>not known yet</gtr:impact><gtr:outcomeId>YQv7uPajwyP</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Llama VHH (WEISS)</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse gene knockout of cathepsin E (aspartic proteinase involved in immune function)</gtr:description><gtr:id>779AC9B7-A6A9-4CFA-9122-D28981859AF1</gtr:id><gtr:impact>offers the opportunity for further studies of cathepsin E in vivo based on this mouse model</gtr:impact><gtr:outcomeId>gMV6xo4MGmk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mouse gene knockout cathepsin E (BENNY CHAIN)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database short RNAs transcribed in CD4+ T-cells</gtr:description><gtr:id>5800B7E5-B2B0-4E4E-9165-E7FF582A1217</gtr:id><gtr:impact>Aid the research of own and other groups in this field, useful resource tool</gtr:impact><gtr:outcomeId>brkGcwr5ySF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Database short RNAs transcribed in CD4+ T-cells (R JENNER)</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>array analysis software</gtr:description><gtr:id>27EAD03B-9A85-43A1-9B5F-5200D7E3196E</gtr:id><gtr:impact>57 downloads so far (in past two months)</gtr:impact><gtr:outcomeId>bheWjRJiUzi</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>agilp (CHAIN)</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Data identifying the binding sites for EBV proteins across the EBV and human genomes</gtr:description><gtr:id>FC4A5610-7707-401A-B82A-03659B119CF1</gtr:id><gtr:impact>too early to say</gtr:impact><gtr:outcomeId>smwBSTuixDn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ChIP-Seq datasets (JENNER)</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Analysis pipeline for ChIP-Seq data</gtr:description><gtr:id>2481C7FC-1F1D-490B-98D4-658AADE497B1</gtr:id><gtr:impact>Aid the research of own and other groups in this field, useful resource tool</gtr:impact><gtr:outcomeId>Zc8iWZ6gKTd</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Analysis pipeline for ChIP-Seq data (R JENNER)</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7F6777E9-1C04-4417-B825-65E5247623E7</gtr:id><gtr:title>PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503b54c73715620166f20a676a65bbdb"><gtr:id>503b54c73715620166f20a676a65bbdb</gtr:id><gtr:otherNames>Karwacz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>Zm4nmUL2geQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BD8E66F-D55E-4E2E-9FAF-50D8C36BB74C</gtr:id><gtr:title>IL-2 regulates expression of C-MAF in human CD4 T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4bd41f5e795706d066b9db464defb69"><gtr:id>d4bd41f5e795706d066b9db464defb69</gtr:id><gtr:otherNames>Rani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>RV1boh8LaQz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63C10B50-A419-40B5-8B52-11575E96CBF8</gtr:id><gtr:title>Varicella zoster immune status in children treated for acute leukemia</gtr:title><gtr:parentPublicationTitle>Pediatric Blood Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f44ccac481ae0f05a98557edb4d2416"><gtr:id>0f44ccac481ae0f05a98557edb4d2416</gtr:id><gtr:otherNames>Patel, SR;</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54590377e78996.91060674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18793328-B2DE-4115-B87B-C2B188F53A7C</gtr:id><gtr:title>Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1810b8703bb427d7da0643038ba59f43"><gtr:id>1810b8703bb427d7da0643038ba59f43</gtr:id><gtr:otherNames>Breuer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>545900fa6cafa5.33255875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6692EA0-5B85-40CC-BD65-9A6460C83401</gtr:id><gtr:title>Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5462276a00fcb7.31134393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C83CB562-F42A-4396-926E-E4B0E2513F90</gtr:id><gtr:title>Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1884440e1cc5bd5524659b0f3184cc6e"><gtr:id>1884440e1cc5bd5524659b0f3184cc6e</gtr:id><gtr:otherNames>McClellan MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_14364_24_22357270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E353C7A-247B-476B-8E44-41C64158ABC2</gtr:id><gtr:title>Nanoscale stiffness topography reveals structure and mechanics of the transport barrier in intact nuclear pore complexes.</gtr:title><gtr:parentPublicationTitle>Nature nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19bb35ed3ee00c0faeb34bf81cc1afc3"><gtr:id>19bb35ed3ee00c0faeb34bf81cc1afc3</gtr:id><gtr:otherNames>Bestembayeva A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1748-3387</gtr:issn><gtr:outcomeId>545b92645281e0.63308683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4CF2404-075F-4A4B-A4CC-708D5E59C4A6</gtr:id><gtr:title>TriTrypDB: a functional genomic resource for the Trypanosomatidae.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdc3d43308c9cdef99af1a55f2556f74"><gtr:id>bdc3d43308c9cdef99af1a55f2556f74</gtr:id><gtr:otherNames>Aslett M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>qzzx9xisV6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E1E80B5-F271-4E0F-A5D8-DE6A5036931B</gtr:id><gtr:title>Mode of virus rescue determines the acquisition of VHS mutations in VP22-negative herpes simplex virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a487439957a8a457771f1264aa85442"><gtr:id>0a487439957a8a457771f1264aa85442</gtr:id><gtr:otherNames>Ebert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545ba859051401.20404011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8CD54A6-B9EE-4CE1-9257-146913F12119</gtr:id><gtr:title>4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>544fbc32a45524.97945788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D64AA8B7-FB7F-4695-9156-A9AEE194031A</gtr:id><gtr:title>Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>545ba503861c55.58805226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC7AD70C-C98E-4A57-B32C-B964180B8F76</gtr:id><gtr:title>HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b80e4206e65c27027c5eb4c5816ed08"><gtr:id>2b80e4206e65c27027c5eb4c5816ed08</gtr:id><gtr:otherNames>Schaller T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14364_24_22174692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E40ED9AA-D801-48DA-A377-6A6DCE5C5F48</gtr:id><gtr:title>Role of DNA methylation in expression and transmission of porcine endogenous retroviruses.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffa6c62cc98c37f05e8ca5982093bbf3"><gtr:id>ffa6c62cc98c37f05e8ca5982093bbf3</gtr:id><gtr:otherNames>Matouskov? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5461db4fd43092.64308376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DB8A3C0-4DF0-4AF7-A73F-5A5694DA7F70</gtr:id><gtr:title>Role of DNA topology in uptake of polyplex molecules by dendritic cells.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6957c278545d5de8c579b913a19c47c3"><gtr:id>6957c278545d5de8c579b913a19c47c3</gtr:id><gtr:otherNames>Dhanoya A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_14364_24_22245608</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78EFB282-BB3D-40E0-8796-A335F72826F6</gtr:id><gtr:title>Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6edbf63ed60ec50dcf00c4121c43bfc"><gtr:id>b6edbf63ed60ec50dcf00c4121c43bfc</gtr:id><gtr:otherNames>Uttenthal B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>5461feced8ad72.96654439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ABA3CC2-8957-458D-BF19-C52FE1BA15BC</gtr:id><gtr:title>DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/442b429f6b5f836091635bace93c3863"><gtr:id>442b429f6b5f836091635bace93c3863</gtr:id><gtr:otherNames>Campos-Perez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>54622623713e18.18968055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABED2AB1-2C8F-4117-88A0-596748AFB0D7</gtr:id><gtr:title>Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41d7ef596be4b3c17e86a591d669f56b"><gtr:id>41d7ef596be4b3c17e86a591d669f56b</gtr:id><gtr:otherNames>Wright GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>sQkGwNm4Afy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40953D7F-8963-4920-8DF9-3AD137B6787D</gtr:id><gtr:title>The ?-globin locus control region in combination with the EF1a short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6db97f40240b631583b97b0f14f1b744"><gtr:id>6db97f40240b631583b97b0f14f1b744</gtr:id><gtr:otherNames>Montiel-Equihua CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>pm_14364_24_22434141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8728C95B-4EE7-47D2-8873-891D0879D65D</gtr:id><gtr:title>p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8? T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeadefcfa805429fe4021215f24d5f0f"><gtr:id>eeadefcfa805429fe4021215f24d5f0f</gtr:id><gtr:otherNames>Henson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>54621ad0047f29.65636332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1234DAD-A8F7-4F4B-B846-E5F36F93F368</gtr:id><gtr:title>Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>ZFG3tQmp52E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A73FF537-96E1-40E0-99E9-95B16AAA3E26</gtr:id><gtr:title>Methods of preparation and analysis of intracellular reverse transcription complexes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>jDRyaS6KkM4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05EBE181-4B00-41C8-9EC2-F747751E35FE</gtr:id><gtr:title>HIV-1 evades innate immune recognition through specific cofactor recruitment.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c1e8ababaaac31f24b1fb218be5bbb"><gtr:id>34c1e8ababaaac31f24b1fb218be5bbb</gtr:id><gtr:otherNames>Rasaiyaah J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545cf024a9da14.90917005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47954555-A895-437C-935F-BD3F3BB3DEFE</gtr:id><gtr:title>Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20756dc4f18233e830a64ecdbd956f4b"><gtr:id>20756dc4f18233e830a64ecdbd956f4b</gtr:id><gtr:otherNames>Rose J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a2fd762ad02a0.39611056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17CCE065-7EC5-407D-B160-6A9F69D39BE0</gtr:id><gtr:title>Structural basis for nuclear import of splicing factors by human Transportin 3.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c749d627f6a6bccbe386923cc5a048"><gtr:id>67c749d627f6a6bccbe386923cc5a048</gtr:id><gtr:otherNames>Maertens GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545b9c82716285.11668961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2029990E-F352-45E3-A73E-29F6649189BF</gtr:id><gtr:title>Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3a3adedd0a4c591c660bb492c735948"><gtr:id>b3a3adedd0a4c591c660bb492c735948</gtr:id><gtr:otherNames>Alpizar YA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn><gtr:outcomeId>kCdaRrupWbw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D7B56E6-A743-41C4-A077-DECCD454BF99</gtr:id><gtr:title>Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiology.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/464a69d208034edf889526a6f84cdb83"><gtr:id>464a69d208034edf889526a6f84cdb83</gtr:id><gtr:otherNames>Weinert LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>doi_55f98598527ce683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E5EAF18-D9A5-412B-8060-EB3191D62335</gtr:id><gtr:title>A quantitative proteomics design for systematic identification of protease cleavage events.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad1854c2a320f5fe8bd8170f93543b53"><gtr:id>ad1854c2a320f5fe8bd8170f93543b53</gtr:id><gtr:otherNames>Impens F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>CYfkjRaVHCS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>285A7CCC-F982-4E07-9EED-7FA26555B35D</gtr:id><gtr:title>Escape from R-peptide deletion in a ?-retrovirus.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd0712031dc167bd02265b80cf8e7e07"><gtr:id>fd0712031dc167bd02265b80cf8e7e07</gtr:id><gtr:otherNames>Schneider IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>MqpGbSrMspK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFE592C0-6B6C-437D-8F33-1A43463DA1A6</gtr:id><gtr:title>Directional migration of recirculating lymphocytes through lymph nodes via random walks.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c31b0a7109bf3aa4318f1c0ba90e0f4d"><gtr:id>c31b0a7109bf3aa4318f1c0ba90e0f4d</gtr:id><gtr:otherNames>Thomas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14364_24_23028891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79BF068E-C113-4A27-BFFB-406DA89261E9</gtr:id><gtr:title>Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation.</gtr:title><gtr:parentPublicationTitle>Xenotransplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9207841ba86b4c96df1f7ef6a4907e10"><gtr:id>9207841ba86b4c96df1f7ef6a4907e10</gtr:id><gtr:otherNames>Busby SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0908-665X</gtr:issn><gtr:outcomeId>5461d971ba4a16.65507368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FD05E48-E31A-4D71-86F2-A69A0CFF197D</gtr:id><gtr:title>Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd2ca761a141ca7db238491b9127a7d8"><gtr:id>bd2ca761a141ca7db238491b9127a7d8</gtr:id><gtr:otherNames>Qasim W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>5461fe2140e195.66589283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A2BDDAD-F62C-45A7-9789-EF3264E2F35E</gtr:id><gtr:title>Improving TCR Gene Therapy for Treatment of Haematological Malignancies.</gtr:title><gtr:parentPublicationTitle>Advances in hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ae2a25850360f65ec63f35761b26fa8"><gtr:id>1ae2a25850360f65ec63f35761b26fa8</gtr:id><gtr:otherNames>Nicholson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_14364_24_22319532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE262B83-477D-4157-B169-3CEFBF20CB30</gtr:id><gtr:title>A lentiviral vector pseudotype suitable for vaccine development.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7ce540024a50b8bd8ff7d2427850e4"><gtr:id>6d7ce540024a50b8bd8ff7d2427850e4</gtr:id><gtr:otherNames>Lopes L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>DV9oAw4PRZV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17C59336-7246-4912-82E0-7AAA42392112</gtr:id><gtr:title>Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387e56f534a8a1ecfad6114c7f9cb2ae"><gtr:id>387e56f534a8a1ecfad6114c7f9cb2ae</gtr:id><gtr:otherNames>Knight S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_14364_24_22696657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88BFA2A9-FFFF-4844-A53D-B8AFCF96089A</gtr:id><gtr:title>RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>545ba41f40f0b9.51180893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC18CE30-168F-459C-8C06-A8D2108373A8</gtr:id><gtr:title>Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b999bff29ae3584c98fe490444298f8b"><gtr:id>b999bff29ae3584c98fe490444298f8b</gtr:id><gtr:otherNames>Perro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn><gtr:outcomeId>syrbx4hTc9w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77EEB20D-B5EB-4592-AA20-27905AB33B0A</gtr:id><gtr:title>Chemical toxicity to keratinocytes triggers dendritic cell activation via an IL-1a path.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42d8c6ca8786a190e5c6d4f3de1426de"><gtr:id>42d8c6ca8786a190e5c6d4f3de1426de</gtr:id><gtr:otherNames>Matjeka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>TwKdk9GurSk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3A49370-5538-405B-A6A0-A04A14ED7B16</gtr:id><gtr:title>Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3a3adedd0a4c591c660bb492c735948"><gtr:id>b3a3adedd0a4c591c660bb492c735948</gtr:id><gtr:otherNames>Alpizar YA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>pm_14364_24_22262303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0535B73-A405-4B81-9FB3-64D26EFBDDB4</gtr:id><gtr:title>In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2467f993d392dfc454bf63c8a0b4df37"><gtr:id>2467f993d392dfc454bf63c8a0b4df37</gtr:id><gtr:otherNames>Snauwaert S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>5462049644c597.02565820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>137475E6-3864-42C5-AC1A-798683E0A590</gtr:id><gtr:title>Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3658d535f2891f5f261f19193a13a89"><gtr:id>c3658d535f2891f5f261f19193a13a89</gtr:id><gtr:otherNames>Lopez-Herrera G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_14364_24_22608502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0942D95D-5CA1-40E8-AFA2-333237AEC488</gtr:id><gtr:title>TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f6a49d89030d49da8ab007e4a081ae"><gtr:id>67f6a49d89030d49da8ab007e4a081ae</gtr:id><gtr:otherNames>Di Pietro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf675846cb4.54365678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB5ACAF8-4C7A-4221-8697-D20B9FA4278D</gtr:id><gtr:title>Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3482145f35e2421667b5dfb612534e99"><gtr:id>3482145f35e2421667b5dfb612534e99</gtr:id><gtr:otherNames>Franks HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>pm_14364_24_23901045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85280940-69ED-42C4-BA55-6667FB525369</gtr:id><gtr:title>Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>gYPeaXtNMcz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5FEF722-2F41-4926-B95C-2801DAFFCAE4</gtr:id><gtr:title>Targeting lentiviral vectors for cancer immunotherapy.</gtr:title><gtr:parentPublicationTitle>Current cancer therapy reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e06e317fad1d8db4dee8b7c2ff53fba"><gtr:id>8e06e317fad1d8db4dee8b7c2ff53fba</gtr:id><gtr:otherNames>Arce F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1573-3947</gtr:issn><gtr:outcomeId>pm_14364_24_22983382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4615E9A7-4F38-483D-A8FA-A8FAFE29AA11</gtr:id><gtr:title>Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c31326fe2d7119af01381f29a5e77427"><gtr:id>c31326fe2d7119af01381f29a5e77427</gtr:id><gtr:otherNames>Thomas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_14364_24_21606483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EADCB8F-80DA-44C3-862B-5EE35862157E</gtr:id><gtr:title>Leishmania-specific surface antigens show sub-genus sequence variation and immune recognition.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>cgSbQoqK2xh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3D3551-8905-47D8-8B3A-470940639D2A</gtr:id><gtr:title>Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors.</gtr:title><gtr:parentPublicationTitle>Journal of immunotherapy (Hagerstown, Md. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49a790dd5935ea90a9bd132b1df62812"><gtr:id>49a790dd5935ea90a9bd132b1df62812</gtr:id><gtr:otherNames>Dai MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1524-9557</gtr:issn><gtr:outcomeId>HUeQv4yvUwY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0647548F-4312-46D4-AD0B-5970C9407B26</gtr:id><gtr:title>Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545ce648427cc1.54108412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22F643AA-83A7-49D9-8D9B-D2FB30EF20EF</gtr:id><gtr:title>Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea</gtr:title><gtr:parentPublicationTitle>PLoS Med.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a7e506c91aea040b4f021737f6da454"><gtr:id>7a7e506c91aea040b4f021737f6da454</gtr:id><gtr:otherNames>Low N;</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545905e63f24d6.91727095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F87CFA5-DFA9-456F-9337-04267206D29D</gtr:id><gtr:title>From Duke to King's: Michael Malim wins the 2010 Retrovirology Prize.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>fipKiqFAVb3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B926810D-BD6B-4F19-AAF9-5CCA7DC01374</gtr:id><gtr:title>Recombination of Globally Circulating Varicella-Zoster Virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b0e7d10e14cea420026b681663aa285"><gtr:id>7b0e7d10e14cea420026b681663aa285</gtr:id><gtr:otherNames>Norberg P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5675e3810e598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48E9DE50-4F8E-4D3F-8203-2AC641E39791</gtr:id><gtr:title>T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_14364_24_23232398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00D92A9B-12C3-49EC-BA02-6286EF5E3467</gtr:id><gtr:title>Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c18528a81eb674069f4bfa80db10e10c"><gtr:id>c18528a81eb674069f4bfa80db10e10c</gtr:id><gtr:otherNames>Kundu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>545ba609eca5c9.06288860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5768FA16-D6BA-4D35-880E-54317DB25ADE</gtr:id><gtr:title>HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfe8677cb938dc1232570dc209d4c71e"><gtr:id>cfe8677cb938dc1232570dc209d4c71e</gtr:id><gtr:otherNames>Tsang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>NUTywM1V2sZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92852917-123B-41B0-9A4C-D623209109E0</gtr:id><gtr:title>Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cd3f637b7203d98d16d16438c247dd"><gtr:id>78cd3f637b7203d98d16d16438c247dd</gtr:id><gtr:otherNames>Ramasubramanyan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_14364_24_23015699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8748F3F8-0D60-46CB-AF46-29AF201621A5</gtr:id><gtr:title>Viruses challenge selectivity barrier of nuclear pores.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc58ada451275ca77331e56070c2ef79"><gtr:id>bc58ada451275ca77331e56070c2ef79</gtr:id><gtr:otherNames>Labokha AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_14364_24_24084236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59D4C120-62A4-4E8E-8A6D-2E7292575628</gtr:id><gtr:title>Innate immunity against HIV: a priority target for HIV prevention research.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6b6ae8702947976cd643c36a0d0bf5d"><gtr:id>f6b6ae8702947976cd643c36a0d0bf5d</gtr:id><gtr:otherNames>Borrow P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>AkmW1MpKmAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7D22A6F-B527-44E4-8498-DBC22F20D041</gtr:id><gtr:title>The HTR1A and HTR1B receptor genes influence stress-related information processing.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90b622be61f8011765e78c73253ee9a3"><gtr:id>90b622be61f8011765e78c73253ee9a3</gtr:id><gtr:otherNames>Mekli K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn><gtr:outcomeId>kVFcJZonaWG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB0D87E7-3A9C-4DEF-86FD-C9C0AA13A8DF</gtr:id><gtr:title>SAMHD1-dependent retroviral control and escape in mice.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>545cf430c3bb39.88718688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED8FFDF6-08AA-4397-8CCF-776500B35CF5</gtr:id><gtr:title>Specific capture and whole-genome sequencing of viruses from clinical samples.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14364_24_22125625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37653294-AAB3-465E-B794-8BDA3853002E</gtr:id><gtr:title>Hepatitis E virus genotype 3 in shellfish, United Kingdom.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/155f8280d7cca12af01ce9b8697b80a9"><gtr:id>155f8280d7cca12af01ce9b8697b80a9</gtr:id><gtr:otherNames>Crossan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>pm_14364_24_23171845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>362AA28C-554D-40B4-9E26-B254B4BAABC0</gtr:id><gtr:title>Characterisation of cytoplasmic DNA complementary to non-retroviral RNA viruses in human cells.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b3036e18483c138459c64953c053bca"><gtr:id>0b3036e18483c138459c64953c053bca</gtr:id><gtr:otherNames>Shimizu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5461df3d3f4029.73016329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EC4801F-E7FF-499C-A482-A06CB41424FD</gtr:id><gtr:title>A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus.</gtr:title><gtr:parentPublicationTitle>Molecular therapy. Nucleic acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7efe725f4c97f66c893fd8e0ccca622"><gtr:id>b7efe725f4c97f66c893fd8e0ccca622</gtr:id><gtr:otherNames>Koh S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546203d6abb149.33630793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15A1FD46-327C-4EC6-88E6-2BB03DA62C6D</gtr:id><gtr:title>Population diversity in batches of the varicella Oka vaccine.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d40ff938ba82c4aaea8a02b20aec1672"><gtr:id>d40ff938ba82c4aaea8a02b20aec1672</gtr:id><gtr:otherNames>Kanda RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_14364_24_21349363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F711EB9-46D7-4E45-BCC2-15FCAC4FDDE9</gtr:id><gtr:title>A model for cofactor use during HIV-1 reverse transcription and nuclear entry.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d849bcff7512ae0e8f595615237a927"><gtr:id>7d849bcff7512ae0e8f595615237a927</gtr:id><gtr:otherNames>Hilditch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn><gtr:outcomeId>545ceeaa89d427.79976674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DF6B7C4-6461-4FDD-901B-ECC0E14DD557</gtr:id><gtr:title>Challenges in T cell receptor gene therapy.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4729bfeb366f412287fa45e3088859f6"><gtr:id>4729bfeb366f412287fa45e3088859f6</gtr:id><gtr:otherNames>Uttenthal BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>pm_14364_24_22610778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3056208A-4E92-45F7-9880-DF7BA9220AFF</gtr:id><gtr:title>The impact of DNA topology on polyplex uptake and transfection efficiency in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Journal of biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6957c278545d5de8c579b913a19c47c3"><gtr:id>6957c278545d5de8c579b913a19c47c3</gtr:id><gtr:otherNames>Dhanoya A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1656</gtr:issn><gtr:outcomeId>KFsPdMSHUz2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>720514BB-A5A9-4A6C-862D-60915A8C5F8D</gtr:id><gtr:title>Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e46d4f7f3d0fd5771d96152a22af04"><gtr:id>16e46d4f7f3d0fd5771d96152a22af04</gtr:id><gtr:otherNames>Blondeau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf0d84bdcb4.52927387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0E2EC07-F72D-45D4-A57E-F5A99B46B491</gtr:id><gtr:title>Genome Sequence of Human Herpesvirus 7 Strain UCL-1.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445e89510add42a0b7afe91dfd55d3ee"><gtr:id>445e89510add42a0b7afe91dfd55d3ee</gtr:id><gtr:otherNames>Donaldson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545ba70ba03f76.49983207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5768AE71-0AF5-458B-91DB-03A98C55A0B5</gtr:id><gtr:title>Importin-7 mediates nuclear trafficking of DNA in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6957c278545d5de8c579b913a19c47c3"><gtr:id>6957c278545d5de8c579b913a19c47c3</gtr:id><gtr:otherNames>Dhanoya A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>pm_14364_24_23067392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B162EBA9-F32C-4DAB-889A-42A097595280</gtr:id><gtr:title>Immunomodulation in the treatment of haematological malignancies.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a76e897c6e4a3f2ef62352c6e32d06d"><gtr:id>4a76e897c6e4a3f2ef62352c6e32d06d</gtr:id><gtr:otherNames>Cesco-Gaspere M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1591-8890</gtr:issn><gtr:outcomeId>cCMvJUGRYf9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE84B824-0603-40A9-8CA0-4FF464BB5695</gtr:id><gtr:title>Endoplasmic reticulum degradation-enhancing a-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/439b5ba9e59cc5db5573c4d16339e4ab"><gtr:id>439b5ba9e59cc5db5573c4d16339e4ab</gtr:id><gtr:otherNames>Guiliano DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>545ce81ebb64f2.77214785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66912BD0-652D-4339-8FB8-E1BCA84B8281</gtr:id><gtr:title>The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496b74cea6ae4d30e25e1e0e77e10e73"><gtr:id>496b74cea6ae4d30e25e1e0e77e10e73</gtr:id><gtr:otherNames>Lanna A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>54621b9f567be4.35318920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DE46229-1567-4555-A869-E80692AC644D</gtr:id><gtr:title>Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides.</gtr:title><gtr:parentPublicationTitle>Chemical biology &amp; drug design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257c231a152a044c321cbb42b71acaa1"><gtr:id>257c231a152a044c321cbb42b71acaa1</gtr:id><gtr:otherNames>Loh B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1747-0277</gtr:issn><gtr:outcomeId>psFxjR3ofws</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>881D6395-8DCC-4938-8A64-51AABAD929AA</gtr:id><gtr:title>Hyperthermia stimulates HIV-1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c4792ad08104c4fbc4dc517aa844e96"><gtr:id>6c4792ad08104c4fbc4dc517aa844e96</gtr:id><gtr:otherNames>Roesch F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_14364_24_22807676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B964804-1EFC-4ACA-A84F-4990FF8BB07E</gtr:id><gtr:title>Interactions between HIV-1 and the cell-autonomous innate immune system.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9d8dc102629560a2c32a6e4c03990a0"><gtr:id>c9d8dc102629560a2c32a6e4c03990a0</gtr:id><gtr:otherNames>Towers GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>545ce8c5b780d7.14999633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35A51F95-C0D8-415C-99DF-DF63FB7BD732</gtr:id><gtr:title>Adherent human alveolar macrophages exhibit a transient pro-inflammatory profile that confounds responses to innate immune stimulation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95729c2d3a47703ec5f65134a7553513"><gtr:id>95729c2d3a47703ec5f65134a7553513</gtr:id><gtr:otherNames>Tomlinson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14364_24_22768282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E396B4BF-C443-4E9F-847A-C58284BAF0ED</gtr:id><gtr:title>Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>585d6866c6d708.66150479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D4DBABB-1272-4989-98AD-53F2C4029832</gtr:id><gtr:title>Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292b41fa56f474420b9e8bde21def9a9"><gtr:id>292b41fa56f474420b9e8bde21def9a9</gtr:id><gtr:otherNames>Mlcochova P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545ce9c12b7844.43410502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FC18E34-1E6F-40AF-A44E-A1487B50F401</gtr:id><gtr:title>Inhibition of retroviral replication by members of the TRIM protein family.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>545cf5bd1f1674.44388746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A163C823-7666-4588-A257-4F421B0C516B</gtr:id><gtr:title>Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>oEPVm2oX3Xq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6A044E6-DA9B-4529-9C2D-426D198AD743</gtr:id><gtr:title>Lentiviral vectors targeted to MHC II are effective in immunization.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe67292440a9860f2973e2f2b6ede31"><gtr:id>0fe67292440a9860f2973e2f2b6ede31</gtr:id><gtr:otherNames>Ageichik A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>NirCNkmY14d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DC8EE98-77CE-40D4-88AC-C69DAAAEA862</gtr:id><gtr:title>Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>doi_55f985985285fffb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43C62F8F-DB8C-49D6-85E5-28AFD18AE4A7</gtr:id><gtr:title>Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387e56f534a8a1ecfad6114c7f9cb2ae"><gtr:id>387e56f534a8a1ecfad6114c7f9cb2ae</gtr:id><gtr:otherNames>Knight S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>5461da4c5292a6.71337242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F0A01C6-FF2F-4385-AAB9-937DBFF0C0BC</gtr:id><gtr:title>Analyses of pig genomes provide insight into porcine demography and evolution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f1b55fc015bced32fa79cdcc24f6210"><gtr:id>1f1b55fc015bced32fa79cdcc24f6210</gtr:id><gtr:otherNames>Groenen MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_14364_24_23151582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A42F308-FA70-4973-9D99-27B5D650FA35</gtr:id><gtr:title>Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e197a00ba92702c3846ba48558e422c4"><gtr:id>e197a00ba92702c3846ba48558e422c4</gtr:id><gtr:otherNames>Raiber EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>b3aQ6Uee5Ax</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6024F04-14C3-4039-8103-2B677ABC965F</gtr:id><gtr:title>Physical modelling of the nuclear pore complex</gtr:title><gtr:parentPublicationTitle>Soft Matter</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2804be1b5e616d83df30d50df62165a"><gtr:id>e2804be1b5e616d83df30d50df62165a</gtr:id><gtr:otherNames>Osmanovic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_14364_c3sm50722j</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>232E2C09-7700-4C30-9ADA-EB4D91BD82E4</gtr:id><gtr:title>Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf71c966f37.69980824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>390BEA6A-5922-421F-83AD-4DD3FDEE91B9</gtr:id><gtr:title>Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0143de37e46d8a91c66f83dee9425f2"><gtr:id>f0143de37e46d8a91c66f83dee9425f2</gtr:id><gtr:otherNames>McCoy LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>545b93648b4567.26912185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5B30797-E53C-48C1-95E0-48E552CA3B53</gtr:id><gtr:title>Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95729c2d3a47703ec5f65134a7553513"><gtr:id>95729c2d3a47703ec5f65134a7553513</gtr:id><gtr:otherNames>Tomlinson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Qkj9eF1v1ie</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53C3717B-A929-41CC-BE14-365E766FC628</gtr:id><gtr:title>Human MHC Class I-restricted high avidity CD4T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.</gtr:title><gtr:parentPublicationTitle>Oncoimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2162-4011</gtr:issn><gtr:outcomeId>5461ff8162a007.66780775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF7A773-2F35-43DE-AE4A-31FA6820BD67</gtr:id><gtr:title>HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf52f9bafc6.36771342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5693167C-0066-4FDC-A5DF-E8542A0504D4</gtr:id><gtr:title>HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9ff52e24b05f5b2cf2786523be6ff84"><gtr:id>d9ff52e24b05f5b2cf2786523be6ff84</gtr:id><gtr:otherNames>Zaitseva L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>Roc2TauARzh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14BC65D3-299D-4AB4-82F1-865FB46D7853</gtr:id><gtr:title>Antibiotic susceptibility and resistance of Staphylococcus aureus isolated from fresh porcine skin xenografts: risk to recipients with thermal injury.</gtr:title><gtr:parentPublicationTitle>Burns : journal of the International Society for Burn Injuries</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9207841ba86b4c96df1f7ef6a4907e10"><gtr:id>9207841ba86b4c96df1f7ef6a4907e10</gtr:id><gtr:otherNames>Busby SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-4179</gtr:issn><gtr:outcomeId>5461de937e0993.93390281</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C2041FE-BC40-42A8-BA84-E4F1D54E1351</gtr:id><gtr:title>Clinical and molecular aspects of the live attenuated Oka varicella vaccine.</gtr:title><gtr:parentPublicationTitle>Reviews in medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1a36b92200ae53de4ccff98ee0c23e9"><gtr:id>a1a36b92200ae53de4ccff98ee0c23e9</gtr:id><gtr:otherNames>Quinlivan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1052-9276</gtr:issn><gtr:outcomeId>545904e19ff5d3.46684087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>060CB632-B007-4710-885D-B639E9DCD860</gtr:id><gtr:title>DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5ada59437f6265f4c2952eb2c8878e9"><gtr:id>f5ada59437f6265f4c2952eb2c8878e9</gtr:id><gtr:otherNames>Le Bert N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>g9mMwkrxbQy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2CEC80B-B8F0-47A2-A52A-EC7E1D3B258F</gtr:id><gtr:title>HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c660668f7b12ef3922555af6a0e45cc5"><gtr:id>c660668f7b12ef3922555af6a0e45cc5</gtr:id><gtr:otherNames>Bichel K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545cf2f6a667e1.20211898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B305420-A2EE-4C31-B97C-9443E0D02891</gtr:id><gtr:title>Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf29f7227bad6014781959a7fbeeeb53"><gtr:id>bf29f7227bad6014781959a7fbeeeb53</gtr:id><gtr:otherNames>Vozzolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>eJr4HtTkcGQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27985D6A-59E0-4301-9CE4-B039B2A0FDC3</gtr:id><gtr:title>Hypochlorous acid: a natural adjuvant that facilitates antigen processing, cross-priming, and the induction of adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d0b5306dd5fb8220a08bc0018485729"><gtr:id>5d0b5306dd5fb8220a08bc0018485729</gtr:id><gtr:otherNames>Prokopowicz ZM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>VmyUfqo164g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D297266-E7F6-436C-905E-1F26272272D7</gtr:id><gtr:title>Multiple roles of the capsid protein in the early steps of HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>pm_14364_24_23041358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AADA871-4186-4C7D-83A0-2C7A88C4A13A</gtr:id><gtr:title>The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation.</gtr:title><gtr:parentPublicationTitle>Xenotransplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f3ffb2b0a04d0fd3ca958ed59b319f4"><gtr:id>4f3ffb2b0a04d0fd3ca958ed59b319f4</gtr:id><gtr:otherNames>Kim MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0908-665X</gtr:issn><gtr:outcomeId>5461e02817e501.04934548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97C9E44A-2D67-4CDD-B690-33CBFC74376D</gtr:id><gtr:title>Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>545cef60192577.23622094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2046B0A4-E674-441D-8D9E-20A25262C4A5</gtr:id><gtr:title>Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dd8773027f8192fe964ca758e49a370"><gtr:id>3dd8773027f8192fe964ca758e49a370</gtr:id><gtr:otherNames>Berry N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>PYRPncNgipL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBA36140-C2B4-4210-99C1-883D603BFEEC</gtr:id><gtr:title>Testing the theory of immune selection in cancers that break the rules of transplantation.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2774e90a1162c72ad08d2d1856e176c"><gtr:id>c2774e90a1162c72ad08d2d1856e176c</gtr:id><gtr:otherNames>Fassati A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn><gtr:outcomeId>qXnC33uyTXm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AD18DAF-91F2-4976-829A-0BCA47869EE9</gtr:id><gtr:title>HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c1631b90dc75345cf78ba845c220f14"><gtr:id>9c1631b90dc75345cf78ba845c220f14</gtr:id><gtr:otherNames>Breckpot K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>sn99z6pTLeo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7753C9B9-658F-4CC1-836A-568788BBDA4E</gtr:id><gtr:title>Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b72f015b18bd51ace1723fdd06f8c0ef"><gtr:id>b72f015b18bd51ace1723fdd06f8c0ef</gtr:id><gtr:otherNames>Simpson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14364_24_22160697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E9B399-4A8C-4804-ADC7-60D6CA26F9C1</gtr:id><gtr:title>Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.</gtr:title><gtr:parentPublicationTitle>Human gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1043-0342</gtr:issn><gtr:outcomeId>pm_14364_24_22909012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91636ADC-ACFB-4105-B77D-F9447F12BDA3</gtr:id><gtr:title>Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honoured.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545b9d0ec101e2.12860597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FB2BCA1-8073-4E84-842D-6D2E62AC1458</gtr:id><gtr:title>Heat shock protein 90 controls HIV-1 reactivation from latency.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16a723b10317ba9aca23158c9a6c8606"><gtr:id>16a723b10317ba9aca23158c9a6c8606</gtr:id><gtr:otherNames>Anderson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545b9c57bbc1f2.55365152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C465B8A7-87FF-41DC-94AF-424CD152F9BF</gtr:id><gtr:title>Bistable collective behavior of polymers tethered in a nanopore.</gtr:title><gtr:parentPublicationTitle>Physical review. E, Statistical, nonlinear, and soft matter physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2804be1b5e616d83df30d50df62165a"><gtr:id>e2804be1b5e616d83df30d50df62165a</gtr:id><gtr:otherNames>Osmanovic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1539-3755</gtr:issn><gtr:outcomeId>pm_14364_24_23005137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCD92EB9-D9E8-4DB3-8A6C-7A723DDFA54A</gtr:id><gtr:title>Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387e56f534a8a1ecfad6114c7f9cb2ae"><gtr:id>387e56f534a8a1ecfad6114c7f9cb2ae</gtr:id><gtr:otherNames>Knight S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>kBHqfgNCErn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3FC6676-E7F2-4164-878D-25A86641459F</gtr:id><gtr:title>Comparison of lentiviral and sleeping beauty mediated a? T cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/650f1d8cfe4962f9cd8bede5aa155319"><gtr:id>650f1d8cfe4962f9cd8bede5aa155319</gtr:id><gtr:otherNames>Field AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546202c21bc206.65344493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5F4BF5F-24F9-420A-BDAA-B2A226C63C3F</gtr:id><gtr:title>Obituary: Kuan-Teh Jeang.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545b9ce25dc589.14488349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F60DBDB-4683-4CBD-91A4-5C848BCBEAA9</gtr:id><gtr:title>IL15 can reverse the unresponsiveness of Wilms' tumor antigen-specific CTL in patients with prostate cancer.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/107069b077fbb6c4b8941b9da67b7b94"><gtr:id>107069b077fbb6c4b8941b9da67b7b94</gtr:id><gtr:otherNames>King JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>Y7c57PuwkvB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12E09880-C3B0-45D5-BC5C-ACAC7F067BF2</gtr:id><gtr:title>RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ad75e0b12c404a6e6d1130d9912a1b3"><gtr:id>1ad75e0b12c404a6e6d1130d9912a1b3</gtr:id><gtr:otherNames>Gunnell A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>585d6863cc52e8.51503623</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E75C2768-2E48-44B0-AA86-E9FAEBC232B3</gtr:id><gtr:title>Epitope spreading contributes to effective immunotherapy in metastatic melanoma patients.</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f26c68aa9ecea466134c7126ebe179aa"><gtr:id>f26c68aa9ecea466134c7126ebe179aa</gtr:id><gtr:otherNames>Hardwick N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn><gtr:outcomeId>J2HwQSuemJZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7BBDC4D-EBA4-4664-8CEB-E8ABF4FAD554</gtr:id><gtr:title>Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e06e317fad1d8db4dee8b7c2ff53fba"><gtr:id>8e06e317fad1d8db4dee8b7c2ff53fba</gtr:id><gtr:otherNames>Arce F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>gnr3JDuFzoP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B12208DA-A1CB-4958-A360-F145E8D2E782</gtr:id><gtr:title>Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease.</gtr:title><gtr:parentPublicationTitle>Cancer immunology, immunotherapy : CII</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f26c68aa9ecea466134c7126ebe179aa"><gtr:id>f26c68aa9ecea466134c7126ebe179aa</gtr:id><gtr:otherNames>Hardwick N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-7004</gtr:issn><gtr:outcomeId>pm_14364_24_22476408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>506F4867-4225-4A74-AE99-18C56921B778</gtr:id><gtr:title>Hsp90: a chaperone for HIV-1.</gtr:title><gtr:parentPublicationTitle>Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42a836d098267a88ca002131499172cb"><gtr:id>42a836d098267a88ca002131499172cb</gtr:id><gtr:otherNames>Low JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-1820</gtr:issn><gtr:outcomeId>545b9c12225975.68813885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F569ED-E3E4-4EB6-BD99-C12659C8DDE1</gtr:id><gtr:title>Molecular immunology lessons from therapeutic T-cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c31326fe2d7119af01381f29a5e77427"><gtr:id>c31326fe2d7119af01381f29a5e77427</gtr:id><gtr:otherNames>Thomas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>CowJkJxjBpK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BA2BD09-0041-46DE-A64D-C3F04A6524F6</gtr:id><gtr:title>Neutrophil myeloperoxidase: soldier and statesman.</gtr:title><gtr:parentPublicationTitle>Archivum immunologiae et therapiae experimentalis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db5a044a32275b8d56e9e59c4dceeae8"><gtr:id>db5a044a32275b8d56e9e59c4dceeae8</gtr:id><gtr:otherNames>Prokopowicz Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0004-069X</gtr:issn><gtr:outcomeId>pm_14364_24_22143159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C053854-EDC2-40DE-8AF5-804A4F6C5084</gtr:id><gtr:title>Error, reproducibility and sensitivity: a pipeline for data processing of Agilent oligonucleotide expression arrays.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d356f7cfe1e9a97102f4025fe5a3215"><gtr:id>3d356f7cfe1e9a97102f4025fe5a3215</gtr:id><gtr:otherNames>Chain B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>hXDWqLZomGw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6596AAD9-AE2C-48B8-BA3D-742D733DAB3A</gtr:id><gtr:title>Upregulation of TRIM5a gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5a genotype has no impact on virus acquisition or vaccination outcome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d601c726d34be556fecbbd27cb08186"><gtr:id>2d601c726d34be556fecbbd27cb08186</gtr:id><gtr:otherNames>Mattiuzzo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>545cf7c8c7a9a9.67726993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0441D45-55C0-4AF0-9227-8CA52F50AFF9</gtr:id><gtr:title>Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe58dc6a098327a26c6ec7f9af7dc38"><gtr:id>9fe58dc6a098327a26c6ec7f9af7dc38</gtr:id><gtr:otherNames>Murchison EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>545b9cb3576192.99381322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAFC7C5C-19AE-480A-B46B-2E9CD45A41A3</gtr:id><gtr:title>Src-mediated regulation of inflammatory responses by actin polymerization.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ef082f96e626cce81f78fe979e8c994"><gtr:id>0ef082f96e626cce81f78fe979e8c994</gtr:id><gtr:otherNames>Kim JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>Vj948Ph95qw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0358DCC1-7DDE-4F15-87DF-FB0B259072C2</gtr:id><gtr:title>Differential requirement for cathepsin D for processing of the full length and C-terminal fragment of the malaria antigen MSP1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a72f69a17c5546c6057221e2636df10"><gtr:id>9a72f69a17c5546c6057221e2636df10</gtr:id><gtr:otherNames>Tulone C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>MSHBrKN6XNv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B611933-8B72-40CF-B1B3-15A8EB7BD293</gtr:id><gtr:title>Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87f4d63086ec2cd0753e751d5ae7fa61"><gtr:id>87f4d63086ec2cd0753e751d5ae7fa61</gtr:id><gtr:otherNames>Scobie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5461dc9b860ad6.33408138</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900950</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>